donepezil	is a	cholinesterase inhibitor
donepezil	treats	Alzheimer’s disease
donepezil	improves	cognitive function
donepezil	reduces	neurofibrillary tangles
donepezil	has	mild nausea
donepezil	causes	bradycardia
donepezil	interacts with	anticholinergics
donepezil	contraindicated in	severe heart block
donepezil	metabolized by	CYP2D6
donepezil	half‑life	70 h
donepezil	dosage	5 mg daily
donepezil	dosage	10 mg daily
donepezil	approved by	FDA
donepezil	approved in	1996
donepezil	brand name	Aricept
rivastigmine	is a	cholinesterase inhibitor
rivastigmine	treats	Alzheimer’s disease
rivastigmine	treats	Parkinson’s dementia
rivastigmine	improves	memory
rivastigmine	causes	nausea
rivastigmine	causes	vomiting
rivastigmine	interacts with	anticholinergics
rivastigmine	contraindicated in	severe hepatic impairment
rivastigmine	metabolized by	CYP2D6
rivastigmine	half‑life	1.5 h
rivastigmine	dosage	1.5 mg twice daily
rivastigmine	dosage	3 mg twice daily
rivastigmine	approved by	FDA
rivastigmine	approved in	2004
rivastigmine	brand name	Exelon
galantamine	is a	cholinesterase inhibitor
galantamine	treats	Alzheimer’s disease
galantamine	improves	attention
galantamine	causes	diarrhea
galantamine	causes	dizziness
galantamine	interacts with	anticholinergics
galantamine	contraindicated in	severe hepatic impairment
galantamine	metabolized by	CYP3A4
galantamine	half‑life	7 h
galantamine	dosage	8 mg daily
galantamine	dosage	16 mg daily
galantamine	approved by	FDA
galantamine	approved in	2001
galantamine	brand name	Razadyne
memantine	is a	NMDA antagonist
memantine	treats	Alzheimer’s disease
memantine	reduces	excitotoxicity
memantine	causes	constipation
memantine	causes	headache
memantine	interacts with	antipsychotics
memantine	contraindicated in	severe renal impairment
memantine	metabolized by	renal excretion
memantine	half‑life	60 h
memantine	dosage	10 mg daily
memantine	dosage	20 mg daily
memantine	approved by	FDA
memantine	approved in	2003
memantine	brand name	Namenda
donepezil	improves	daily living activities
rivastigmine	improves	daily living activities
galantamine	improves	daily living activities
memantine	improves	daily living activities
donepezil	reduces	caregiver burden
rivastigmine	reduces	caregiver burden
galantamine	reduces	caregiver burden
memantine	reduces	caregiver burden
donepezil	may delay	disease progression
rivastigmine	may delay	disease progression
galantamine	may delay	disease progression
memantine	may delay	disease progression
donepezil	used in	mild‑to‑moderate Alzheimer’s
rivastigmine	used in	mild‑to‑moderate Alzheimer’s
galantamine	used in	mild‑to‑moderate Alzheimer’s
memantine	used in	moderate‑to‑severe Alzheimer’s
donepezil	contraindicated in	severe hepatic disease
rivastigmine	contraindicated in	severe hepatic disease
galantamine	contraindicated in	severe hepatic disease
memantine	contraindicated in	severe hepatic disease
donepezil	may cause	weight loss
rivastigmine	may cause	weight loss
galantamine	may cause	weight loss
memantine	may cause	weight loss
donepezil	can be combined with	memantine
rivastigmine	can be combined with	memantine
galantamine	can be combined with	memantine
donepezil	improves	functional status
rivastigmine	improves	functional status
galantamine	improves	functional status
memantine	improves	functional status
donepezil	reduces	mortality risk
rivastigmine	reduces	mortality risk
galantamine	reduces	mortality risk
memantine	reduces	mortality risk
donepezil	reduces	hospitalization rate
rivastigmine	reduces	hospitalization rate
galantamine	reduces	hospitalization rate
memantine	reduces	hospitalization rate
donepezil	associated with	improved quality of life
rivastigmine	associated with	improved quality of life
galantamine	associated with	improved quality of life
